BIOE: the cash flow

MyFinsight

For the quarter ending 2026-03-31, BIOE had $8,807 increase in cash & cash equivalents over the period.

Cash Flow	2026-03-31	2025-09-30	2025-06-30
Gain from disposal of discontinued operations	-	0	0
Other current liability	-	5,513	-1,305
Loss on disposal of fixed assets	-	0	0
Net income (loss)	338,263	12,998	-145,888
Depreciation and amortization expense	-117	58	118
Operating lease expense	-29,967	9,400	25,346
Accounts receivable	-17,980	0	-155
Prepaid expenses and other receivables	308,871	-2	-187,794
Prepayment and deposits	173,235	43,161	21,104
Impairment loss of rou asset	-	0	-
Accounts payable	-37,625	-85	-7,046
Payment of lease liability	-	0	0
Receivable from sale of bep	-	0	-
Customer deposit	-880,024	539,360	103,164
Accrued interest	-	0	0
Net cash provided by operating activities from continuing operations	-	186,973	141,728
Tax payable	9,944	-810	494
Net cash used in operating activities from discontinued operations	-	0	0
Accrued liability and other payables	327,189	-336,302	-
Net cash used in operating activities	-740,671	186,973	141,728
Repayment of sba loan	-	316	665
Change in bank overdraft	-1,531	-6,966	6,966
Loan from shareholder	-	224,050	419,400
Loan to shareholder	-419,000	-	-
Repayment from shareholder	1,372,800	-375,000	-568,800
Net cash used in financing activities from continuing operations	-	-158,232	-143,099
Repayment of sba loan	322	-	-
Net cash used in financing activities from discontinued operations	-	0	0
Issue of common stocks	440,000	-	-
Net cash provided by financing activities	749,478	-158,232	-143,099
Net increase (decrease) in cash	8,807	28,741	-1,371
Cash at the beginning of period	28,741	1,371	-
Cash at the end of period	36,177	28,741	-

Unit: Dollar. Numbers labeled with * are estimated quarterly values.